NCT06227429 - A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Hereditary Tyrosinemia, Type I

Interventions

DRUG

Nitisinone

According to prescription

Trial Locations (4)

NOT_YET_RECRUITING

Swedish Orphan Biovitrum Research Site, Beijing

NOT_YET_RECRUITING

Swedish Orphan Biovitrum Research Site, Chongqing

RECRUITING

Swedish Orphan Biovitrum Research Site, Hefei

RECRUITING

Swedish Orphan Biovitrum Research Site, Wuhan